[1]
Xu, J. 2024. Treatments for age-related macular degeneration and novel options using CCR3 antagonists. Highlights in Science, Engineering and Technology. 109, (Jul. 2024), 1–5. DOI:https://doi.org/10.54097/d1jyyr11.